A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and Infusion HRS-9190 in Healthy Adults
Clinical trial NCT07142850 · COMPLETED
Trial details
- NCT number
- NCT07142850
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2025-10-31
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.